Lilly to transform chronic disease management with Sigilon Therapeutics acquisition
Pharmaceutical giant Eli Lilly and Company (Lilly) has announced its definitive agreement to acquire Nasdaq-listed biopharma innovator Sigilon Therapeutics, in a move set to significantly ... Read More
Medtronic to acquire South Korean medical device company EOFlow
Ireland-based healthcare technology company Medtronic has announced an agreement to acquire EOFlow, a South Korean medical device company, for a total consideration of KRW 971 ... Read More
Medtronic secures $337m from Blackstone to develop diabetes technologies
Irish medical device company Medtronic has secured a $337 million product investment from Blackstone Life Sciences for advancing new, innovative products particularly designed to ease the ... Read More
Xeris Pharmaceuticals begins Phase 2 trial for glucagon in Type 1 diabetes patients
Xeris Pharmaceuticals, a specialty pharmaceutical company based in Chicago, has announced the commencement of dosing in its phase 2 clinical trial. The trial aims to ... Read More
Smokers with Diabetes have high risk of early death!
As per the recent study by Kavita Garg, an Indian-origin researcher at the University of Colorado-Denver in US, diabetic persons with heavy smoking habit have ... Read More